Advanced in Pulmonary Fibrosis

Dr. Adrian G. Divittorio

Pulmonary Medicine | Intensive Care Medicine
Imc-Diagnostic And Medical Clinic LLC
1700 Spring Hill Ave, Suite 100, 
Mobile, AL 
Accepting New Patients
Advanced in Pulmonary Fibrosis
Imc-Diagnostic And Medical Clinic LLC
1700 Spring Hill Ave, Suite 100, 
Mobile, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adrian Divittorio is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Mobile, Alabama. Dr. Divittorio is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Atypical Pneumonia, Hospital-Acquired Pneumonia, COVID-19, Advanced Bronchoscopy, and Gastrostomy. Dr. Divittorio is currently accepting new patients.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Critical Care Medicine in AL
Hospital Affiliations
Mobile Infirmary Medical Center
Thomas Hospital
Languages Spoken
English
Italian
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC
1700 Spring Hill Ave, Suite 100, Mobile, AL 36604
Other Locations
IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC
5 Mobile Infirmary Cir, Suite G805, Mobile, AL 36607
IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC
95 Shell Rd, Saraland, AL 36571

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Distinguished in Pulmonary Fibrosis
Dr. Sardar I. Babar
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Pulmonary Fibrosis
Dr. Sardar I. Babar
Pulmonary Medicine | Intensive Care Medicine

Singing River Health System

3101 Denny Ave, Suite 200, 
Pascagoula, MS 
 (34.6 miles away)
228-872-1951
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sardar Babar is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Pascagoula, Mississippi. Dr. Babar is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Cholesterol Pneumonia, Acute Interstitial Pneumonia, Pulmonary Veno-Occlusive Disease, Gastrostomy, and Advanced Bronchoscopy. Dr. Babar is currently accepting new patients.

Advanced in Pulmonary Fibrosis
Dr. Enrique Diaz-Guzman
Pulmonary Medicine | Intensive Care Medicine
Advanced in Pulmonary Fibrosis
Dr. Enrique Diaz-Guzman
Pulmonary Medicine | Intensive Care Medicine

Pensacola Lung Group, M.D.'S, P.A.

4700 Bayou Blvd, Suite 6, 
Pensacola, FL 
 (54.2 miles away)
850-477-9253
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Enrique Diaz-Guzman is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Pensacola, Florida. Dr. Diaz-Guzman is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Lung Metastases, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, and Gastrostomy. Dr. Diaz-Guzman is currently accepting new patients.

Advanced in Pulmonary Fibrosis
Dr. Rammohan S. Rao
Pulmonary Medicine | Intensive Care Medicine
Advanced in Pulmonary Fibrosis
Dr. Rammohan S. Rao
Pulmonary Medicine | Intensive Care Medicine

Pulmonary Critical Care And Sleep Disorders Medicine PA

435 Airport Blvd, 
Pensacola, FL 
 (52.8 miles away)
850-435-7448
Languages Spoken:
English, Hindi, Telugu, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Rammohan Rao is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Pensacola, Florida. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, Asthma, and Advanced Bronchoscopy. Dr. Rao is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Divittorio's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile